Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab
Article in Multiple Sclerosis and Related Disorders (December 2019)
The most recent citing publications are shown below. View all 59 publications that cite this research output on Dimensions.
Article in Multiple Sclerosis and Related Disorders (December 2019)
Article in Journal of Neurology (July 2019)
Article in Autoimmunity Reviews (January 2019)